These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8578824)

  • 1. Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection.
    Danenberg HD; Ben-Yehuda A; Zakay-Rones Z; Friedman G
    Vaccine; 1995; 13(15):1445-8. PubMed ID: 8578824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone enhances influenza immunization in aged mice.
    Danenberg HD; Ben-Yehuda A; Zakay-Rones Z; Friedman G
    Ann N Y Acad Sci; 1995 Dec; 774():297-9. PubMed ID: 8597470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects.
    Danenberg HD; Ben-Yehuda A; Zakay-Rones Z; Gross DJ; Friedman G
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2911-4. PubMed ID: 9284718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge.
    Moriyama M; Chino S; Ichinohe T
    Vaccine; 2017 Feb; 35(7):1001-1007. PubMed ID: 28111142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of sequential annual vaccination and of DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly.
    Ben-Yehuda A; Danenberg HD; Zakay-Rones Z; Gross DJ; Friedman G
    Mech Ageing Dev; 1998 May; 102(2-3):299-306. PubMed ID: 9720660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge.
    Wang X; Zhang W; Liu F; Zheng M; Zheng D; Zhang T; Yi Y; Ding Y; Luo J; Dai C; Wang H; Sun B; Chen Z
    Arch Virol; 2012 Aug; 157(8):1451-61. PubMed ID: 22552485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.
    Baldwin SL; Hsu FC; Van Hoeven N; Gage E; Granger B; Guderian JA; Larsen SE; Lorenzo EC; Haynes L; Reed SG; Coler RN
    Front Immunol; 2018; 9():295. PubMed ID: 29515589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection.
    Liu J; Wu J; Wang B; Zeng S; Qi F; Lu C; Kimura Y; Liu B
    J Med Virol; 2014 May; 86(5):886-94. PubMed ID: 24122866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines.
    Arulanandam BP; Mittler JN; Lee WT; O'Toole M; Metzger DW
    J Immunol; 2000 Apr; 164(7):3698-704. PubMed ID: 10725728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.
    Major D; Chichester JA; Pathirana RD; Guilfoyle K; Shoji Y; Guzman CA; Yusibov V; Cox RJ
    Hum Vaccin Immunother; 2015; 11(5):1235-43. PubMed ID: 25714901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.
    Lee YT; Ko EJ; Lee Y; Lee YN; Bian Z; Liu Y; Kang SM
    J Virol; 2016 Aug; 90(15):6746-6758. PubMed ID: 27194758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of regulatory T cells augments induction of protective immune responses by influenza virus-like particles in aged mice.
    Wen Z; Wang X; Dong K; Zhang H; Bu Z; Ye L; Yang C
    Microbes Infect; 2017 Dec; 19(12):626-634. PubMed ID: 28899815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination.
    Petersson P; Hedenskog M; Alves D; Brytting M; Schröder U; Linde A; Lundkvist A
    Vaccine; 2010 Sep; 28(39):6491-7. PubMed ID: 20637767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal hydroxypropyl-β-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection.
    Kusakabe T; Ozasa K; Kobari S; Momota M; Kishishita N; Kobiyama K; Kuroda E; Ishii KJ
    Vaccine; 2016 Jun; 34(27):3191-3198. PubMed ID: 27160037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice.
    Cataldo DM; Van Nest G
    Vaccine; 1997 Nov; 15(16):1710-5. PubMed ID: 9364672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.